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Enamel is the most highly mineralized vertebrate tissue,
composed of 96% mineral and 4% organic material
and water. During amelogenesis, the ameloblast secretes
matrix proteins and is responsible for creating and
maintaining an extracellular environment favorable for
mineral deposition (1). Amelogenin, the predominant
enamel matrix protein, has been shown to undergo self-
assembly to form spherical or oblate-shaped nanopar-
ticles (2–4), as well as elongated structures (5–7), and is
believed to play an essential role in guiding the for-
mation of ordered arrays of apatitic crystals during
enamel development (5, 8–12). In particular, both the
N-terminal domain (containing the only phosphate
group on serine 16) and the hydrophilic C-terminal
domain of full-length amelogenin (Fig. 1) have been
shown to be critical for proper enamel formation
(13–16). It is also believed that during enamel mineral
growth, the concentration of free calcium ions is
regulated, in part, by the binding of calcium to enamel
proteins and their proteolytic cleavage products
(17, 18).
The leucine-rich amelogenin peptide (LRAP), a 56-
amino-acid alternative splice product of the amelogenin
gene found throughout amelogenesis and composed of
the ﬁrst 33 N-terminal and the last 23 C-terminal amino
acids of full-length amelogenin (Fig. 1), has recently been
shown by us to share similar behavioral properties with
amelogenin with respect to self-assembly and its ability
to regulate crystal growth in vitro (19, 20). As in solution
(19), LRAP has also been shown to assemble into nan-
ospheres on ﬂuoroapatite (21) and on surfactant-coated
gold surfaces (22). Furthermore, it has been shown (23)
that non-phosphorylated LRAP [LRAP()P)] and
recombinant full-length human amelogenin (rH174) have
the same capacity to bind calcium (i.e. four to six calcium
ions per molecule), although the calcium aﬃnity constant
for LRAP was greater than that for the full-length
amelogenin. Based on similarities of structure and
behavior, LRAP has allowed us to investigate the
potential role of speciﬁc amino-acid domains of amelo-
genin and phosphorylation in protein self-assembly using
dynamic light scattering (DLS) and transmission electron
microscopy (TEM). Such studies have illustrated poten-
tially important diﬀerences in the self-assembly behavior
of phosphorylated LRAP [(LRAP(+P)] and LRAP()P)
(19).
The aim of the present study was to extend these recent
ﬁndings using small angle X-ray scattering (SAXS), to
investigate further the role of phosphorylation in LRAP
self-assembly, in the presence and absence of calcium,
through comparative studies of LRAP(+P) and
LRAP()P) forms of LRAP (Fig. 1).
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Amelogenin undergoes self-assembly and plays an essential role in guiding enamel
mineral formation. The leucine-rich amelogenin peptide (LRAP) is an alternative
splice product of the amelogenin gene and is composed of the N terminus (containing
the only phosphate group) and the C terminus of full-length amelogenin. This study
was conducted to investigate further the role of phosphorylation in LRAP self-
assembly in the presence and absence of calcium using small angle X-ray scattering
(SAXS). Consistent with our previous dynamic light-scattering ﬁndings for phos-
phorylated (+P) and non-phosphorylated ()P) LRAP, SAXS analyses revealed radii
of gyration (Rg) for LRAP()P) (46.3–48.0 A˚) that were larger than those for
LRAP(+P) (25.0–27.4 A˚) at pH 7.4. However, added calcium (up to 2.5 mM) induced
signiﬁcant increases in the Rg of LRAP(+P) (up to 46.4 A˚), while it had relatively
little eﬀect on LRAP()P) particle size. Furthermore, SAXS analyses suggested com-
pact folded structures for LRAP()P) in the presence and absence of calcium, whereas
the conformation of LRAP(+P) changed from an unfolded structure to a more
compact structure upon the addition of calcium. We conclude that the single phos-
phate group in LRAP(+P) induces functionally important conformational changes,
suggesting that phosphorylation may also inﬂuence amelogenin conformation and
protein–mineral interactions during the early stages of amelogenesis.
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Material and methods
Preparation of amelogenin peptides
LRAP(+P) and LRAP()P) forms of porcine LRAP (56
amino acids) were synthesized commercially (NEO Peptide,
Cambridge, MA, USA) and puriﬁed as previously described
(24). Lyophilized peptides were weighed and dissolved in
distilled deionized water at room temperature to yield stock
solutions of 5–6 mg ml)1 of peptide. The solutions were
kept at room temperature for 30 min and then stored at 4C
for 24 h before checking complete dissolution by DLS.
Peptide stock solutions were centrifuged (10,900 · g, 4C,
20 min) just before use.
SAXS measurements
Aliquots of peptides were adjusted to a pH of 7.4 with
small amounts of KOH and HCl to obtain ﬁnal concentra-
tions of 2 mg ml)1 (0.31 mM) and 5 mg ml)1 (0.76 mM) of
LRAP (total volume 70 ll). In selected experiments, calcium
chloride was added to peptide solutions before adjustment of
pH to yield ﬁnal concentrations of 0.76–2.5 mM calcium
(total volume= 70 ll). Hence, on a molar basis, the calcium
to protein ratios ranged from 1.0 to 8.1. All sample prepa-
rations were carried out at room temperature.
Solution X-ray scattering experiments were carried out at
the National Synchrotron Light Source at Brookhaven
National Laboratory, on beamline X9 (25). The X-ray
wavelength was 0.918 A˚ and the sample-detector distance
was 3.4 m. The sample holder was a 0.9-mm-diameter
quartz capillary tube that was open at both ends to allow
continuous ﬂow of the sample to avoid X-ray damage. Each
measurement required 15 ll of sample and an exposure time
of 30 s at 13C. Triplicate measurements were conducted for
each experiment. The two-dimensional images acquired on a
PILATUS 300K detector (Dectris, Baden, Switzerland)
were averaged into one-dimensional scattering curves and
then water scattering was subtracted using the pyXS soft-
ware developed at the beamline. Solution X-ray scattering
data were further analyzed using Primus software (26). The
data consisted of the scattering vector, s [deﬁned as s = 2p/
d or 4psin(h)/k], and the corresponding intensity, I(s). As
noted in the Results section, Guinier and Kratky plots were
used to analyze the data. Guinier analyses consisted of the
plotting of log I vs. s2 at very low s values and were used to
determine the radius of gyration, Rg, and the extrapolated
intensity at the zero scattering angle, Io, with Rg being the
mass distribution of the macromolecule around its center of
gravity (27). Kratky analyses were carried out by plotting
I(s) · s2 vs. s and provided information on peptide fold-
ing, as described later (28). The number of molecules per
particle was estimated using the following formula: N =
(VS · NA · dp)/FW; where, VS = (4pRg3)/3, the density of
the protein dp = 1.44 g cm
)3 (3), NA is the Avogadro
constant, and FW = 6537.52 Da.
Results
Size of particles formed
Small angle X-ray scattering enables determination of
the molecular size, shape, and conformational change of
a protein molecule in solution. As shown in Fig. 2, the
scattering generally exhibited fairly good linear depen-
dence [log I(s) vs. s2] at low s, indicating little to no bulk
aggregation and allowing further data processing. As
shown in Table 1, Guinier plots revealed that the Rg was
48.0 ± 0.05 A˚ for LRAP()P) but only 25.0 ± 0.50 A˚
for LRAP(+P) (both at 2 mg ml)1, 13C, pH 7.4), in the
absence of added calcium. The Rg values for each peptide
were very similar when the peptide concentration was
increased to 5 mg ml)1, with an Rg of 46.3 ± 0.02 A˚ for
LRAP()P) and an Rg of 27.4 ± 0.08 A˚ for LRAP(+P),
under the same experimental conditions. The addition of
2.5 mM calcium to 2 mg ml)1 solutions of peptide,
however, induced a signiﬁcant increase in the Rg for
LRAP(+P) to 43.9 ± 0.05 A˚, but it had relatively little
eﬀect on the Rg of LRAP()P), with a value of
46.2 ± 0.03 A˚ being determined (Table 1). Similar re-
sults were obtained for 5 mg ml)1 peptide solutions
containing 2.5 mM calcium, yielding Rg values for
LRAP(+P) and LRAP()P) of 46.4 ± 0.06 A˚ and
53.9 ± 0.06 A˚, respectively. As also shown in Table 1,
using peptide concentrations of 5 mg ml)1, increasing
concentrations of calcium added to LRAP()P) solutions
resulted in a progressive, but slight, increase in the Rg
values, whereas increased calcium concentrations re-
sulted in marked concentration-dependent increases in
the Rg values for LRAP(+P).
Increased Io values per unit peptide concentration (c),
Io/c (Table 1), calculated for the LRAP(+P) samples,
however, were consistent with peptide self-assembly (29),
as particle sizes (Rg) increased by an overall factor of
around two upon the addition of higher concentrations
of calcium. In contrast, as clearly seen in 5 mg ml)1
samples, a much smaller increase in Io/c was observed for
LRAP()P) upon the addition of calcium. Similar
increases in the number of molecules per particle were
also observed (Table 1). Overall, under comparable
conditions, Io values were larger for LRAP()P) than for
LRAP(+P) and corresponded to a somewhat greater
number of molecules per particle.
Determination of conformational changes
Kratky plots [I(s) · s2 vs. s] of SAXS data present char-
acteristic and distinctly diﬀerent shapes for globular fol-
Fig. 1. Amino-acid sequences of the full-length porcine amelogenin (P173) and the phosphorylated (+P) and non-phosphorylated
()P) leucine-rich amelogenin peptide (LRAP). Note that LRAP is composed exclusively of the N- and C-terminal domains (shown in
bold type) of the full-length molecule.
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ded molecules and extended-chain or random-coil mole-
cules of similar molecular mass (30–32). Globular mac-
romolecules follow Porods law and have bell-shaped
curves as the clearly deﬁned surface of the protein leads to
a drop in intensity with the fourth power of s (31), whereas
extended molecules, such as unfolded peptides, lack this
peak and have a plateau or increase slightly in the larger s
range. As shown in Fig. 3A,B,D, the Kratky plot of
LRAP()P) data in the absence of calcium showed a bell-
shaped curve, indicating a globular structure. The addi-
tion of up to 2.5 mM calcium did not induce an apparent
conformational change, as LRAP()P) exhibited similar
bell-shaped curves in the presence of various concentra-
tions of calcium (0.76–2.5 mM), as it did in its absence
(Fig. 3A,B,D). On the contrary, in the absence of calcium,
LRAP(+P) showed a plateau indicating an unfolded
extended random structure (Fig. 3A–C). However, a
prominent peak appeared upon the addition of 2.5 mM
calcium, suggesting the formation of a more globular
LRAP(+P)–Ca structure (Fig. 3A,B). The extent of
folding of the LRAP(+P) peptide was also found to be
dependent upon the concentration of calcium added
(Fig. 3C). The addition of 0.76 mM calcium induced the
formation of a very slight peak, suggesting that the pep-
tide remained mostly in the unfolded state with the
appearance of some globular features; upon the addition
of 1.5 mM calcium the peak appeared more pronounced,
indicating an increase in peptide folding. With the addi-
tion of 2.5 mM calcium, the peak of the Kratky plot for
LRAP(+P) became even more pronounced and began to
resemble that of the non-phosphorylated LRAP()P)
peptide, although the curves remained somewhat distinct
at higher values of s (Fig. 3A–D).
Discussion
Leucine-rich amelogenin peptide, like amelogenin, is a
phosphorylated protein that is secreted with a single
phosphate group on serine 16 (33). Previous studies from
our laboratory have shown that this single phosphate
group has a major inﬂuence on the properties of
amelogenin. In particular, in comparison with their non-
phosphorylated (recombinant or synthetic) counterparts,
phosphorylated (native and synthetic) forms of full-
length porcine amelogenin (P173) (7), truncated porcine
amelogenin P148 (8), full-length LRAP(+P) (19), and a
truncated form of LRAP [LRAP(+P,)CT] (20) all
exhibit the capacity to stabilize amorphous calcium
phosphate (ACP) eﬀectively [i.e. prevent its transforma-
tion to crystalline hydroxyapatite (HA)], under experi-
mental conditions designed to support the spontaneous
formation of calcium phosphates in vitro. In sharp con-
trast to these ﬁndings, non-phosphorylated forms of full-
length amelogenin and full-length LRAP were shown to
guide the formation of ordered bundles of apatitic crys-
tals (5, 8, 19). This latter behavior has been attributed to
the ability of full-length amelogenin (6, 7, 15, 34) and
LRAP (19) to form higher-order chain-like structures
under speciﬁed conditions of pH. The presence of calcium
has also previously been shown to enhance the formation
of chain-like structures of recombinant full-length mouse
rM179 (5) and human rH174 (35), amelogenin, and
LRAP (19). Notably, as shown in the latter study, particle
sizes and the formation of chain-like structures were en-
hanced to a greater degree for the phosphorylated form of
LRAP. This conclusion was based on DLS and TEM
observations. Our present SAXS ﬁndings support this
conclusion and further demonstrate that the presence of
calcium has a profound eﬀect on the size and confor-
mation of LRAP(+P) and little eﬀect on those charac-
teristics of LRAP()P). This eﬀect is caused by the
presence of a single phosphate group on serine 16.
Guinier (Table 1) and Kratky (Fig. 3) analyses re-
vealed further assembly and enhanced folding of
LRAP(+P) upon the addition of calcium (Fig. 3A–C).
Further assembly with added calcium is indicated
(Table 1) by marked increases in Rg values, in estimates
of the number of molecules per particle, and in Io/c
values. However, it should be noted that Io values are
aﬀected by factors other than particle size (i.e. Rg), such
as particle shape and particle density, in the proportion
Fig. 2. The Guinier region of the scattering curve for phos-
phorylated leucine-rich amelogenin peptide [LRAP(+P)] (A)
and non-phosphorylated leucine-rich amelogenin peptide
[LRAP()P)] (B) data recorded in the absence and in the pres-
ence of 0.76–2.5 mM calcium chloride (CaCl2). Curves in (A)
and (B) exhibit fairly good linear dependence of log I(s) vs. s2,
indicating little to no bulk aggregation. Data shown are for
5 mg ml)1 peptide concentrations. I(s), intensity of s; s, scat-
tering vector.
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Io/c  (qparticle)qsolvent)2 · Vparticle, where q indicates
(electron) density and Vparticle indicates the volume of a
single particle (27). Although our present analyses do not
take potential diﬀerences in these latter factors into
consideration, LRAP(+P) and LRAP()P) were found
to behave quite diﬀerently in the absence and presence of
calcium, particularly with respect to folding. In contrast
to that seen with LRAP(+P), as observed previously
using circular dichroism (36), LRAP()P) does not un-
dergo signiﬁcant conformational change upon the addi-
tion of calcium (Fig. 3A,B,D). Moreover, as
demonstrated here (Fig. 3), LRAP(+P) exhibits a more
unfolded structure than LRAP()P), particularly in the
absence and presence of lower concentrations of calcium.
It appears that in the presence of calcium, unfolded
LRAP(+P) molecules assemble to form more globular-
like structures and the process is primarily triggered by
calcium concentration (Table 1 and Fig. 3). As seen in
Fig. 3, however, diﬀerences in Kratky plots for
LRAP(+P) and LRAP()P), which persist even in the
presence of the highest calcium concentration studied at
high s values, suggest that LRAP(+P) remains some-
what more unfolded than LRAP()P) under these con-
ditions. Additional studies will be needed to provide
insight into other potential diﬀerences in LRAP(+P)
and LRAP()P) self-assembly, as brieﬂy noted above.
The remarkable conformational diﬀerence between
LRAP(+P) and LRAP()P) shown here oﬀers a possible
explanation for the diﬀerences observed in assembly
behavior and for the eﬀects that these peptides have on
calcium phosphate precipitation in vitro. Changes in the
folding of LRAP(+P), induced by the addition of cal-
cium, may result from favorable calcium interactions
with speciﬁc peptide sites that are exposed in the less-
folded LRAP(+P) molecules. Such interactions lead to
an enhancement of protein–protein interactions and to
the formation of higher-order anisotropic chain-like
structures (19). Hence, based on our present ﬁndings, it
is concluded that the presence of the single phosphate
group in LRAP induces functionally important confor-
mational changes in the protein structure that favor the
formation of higher-order protein assemblies. Accord-
ingly, speciﬁc structure-changing calcium interactions
that take place with LRAP(+P) do not occur with the
non-phosphorylated LRAP()P), as LRAP()P) is inher-
ently more tightly folded and key calcium-binding sites
are concealed. Furthermore, observed diﬀerences in
folding, and the tendency for LRAP(+P) to form less
folded structures in the absence and presence of calcium,
may also explain why phosphorylated LRAP(+P) is
much more eﬀective in stabilizing ACP nanoparticles
and preventing the transformation of ACP into HA. The
more open structure and the calcium-induced folding of
LRAP(+P), in the presence of calcium and phosphate
under mineralizing conditions, could lead to a more
eﬀective sequestration of forming ACP nanoparticles
that prevents the transformation of ACP to HA. The
fact that LRAP()P) has been shown to stabilize ACP
only transiently (19) is consistent with the present ﬁnd-
ings and this developing hypothesis on the eﬀect of
phosphorylation on protein conformation and mineral-
ization. However, it is important to consider that pre-
vious ﬁndings also show that LRAP()P) (19), like the
full-length non-phosphorylated amelogenins rM179 (5)
and rP172 (8), has the capacity to regulate the formation
of ordered arrays of apatitic crystals by guiding the
alignment, fusion, and subsequent transformation of the
initially formed ACP nanoparticles (8). This capability
Table 1
Guinier analyses of eﬀect of peptide and calcium concentrations on particle size
Peptide
concentration [CaCl2] (mM)
Guinier
Number of molecules
per particleRg (A˚) Error Io Io/c
2 mg ml)1
LRAP(+P) 0 25.0 0.489 8.39 4.2 9
2.5 43.9 5.34E-02 73.12 36.6 47
LRAP()P) 0 48.0 5.34E-02 100.33 50.2 61
2.5 46.2 2.59E-02 85.87 42.9 55
5 mg ml)1
LRAP(+P) 0 27.4 7.77E-02 20.304 4.06 11
0.76 35.5 5.32E-02 51.829 10.4 25
1.5 40.7 4.08E-02 115.14 23.0 37
2.5 46.4 6.41E-02 165.03 33.0 56
LRAP()P) 0 46.3 2.20E-02 230.17 46.0 55
0.76 49.5 2.80E-02 254.58 50.9 67
1.5 52.0 4.30E-02 286.57 57.3 78
2.5 53.9 6.24E-02 302.99 60.6 87
LRAP()P) and LRAP(+P) exhibit similar radii of gyration (Rg) at 2 and 5 mg ml
)1. The Rg of LRAP(+P) is half that of LRAP()P)
in the absence of calcium at pH7.4. Rg and Io/c for LRAP()P) increased slightly upon the addition of up to 2.5 mM calcium,
whereas marked and progressive increases in these parameters were observed in the presence of LRAP(+P), upon the addition of
calcium. The estimated number of molecules calculated from the Rg is presented for comparison purposes.
Io, the extrapolated intensity at zero scattering angle; Io/c, the Io value per unit peptide concentration; LRAP, leucine-rich amelogenin
peptide; LRAP()P), non-phosphorylated leucine-rich amelogenin peptide; LRAP(+P), phosphorylated leucine-rich amelogenin
peptide.
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was found to depend on the presence of the hydrophilic
C terminus in both amelogenin and LRAP (20). Based
on these collective ﬁndings, additional processes [e.g.
proteolysis or dephosphorylation, as we have recently
discussed (19)] may be involved in vivo to trigger the
subsequent transformation of initially formed ACP
particles, as found in the early stages of developing en-
amel (37). We propose that initially formed ACP mineral
in developing enamel is stabilized by native phosphory-
lated amelogenins that guide the accumulation and lin-
ear arrangement of amorphous nanoparticles which
serve as precursors to enamel crytallites.
In conclusion, we have shown that the single phos-
phate group in LRAP(+P) induces functionally impor-
tant conformational changes, particularly with respect to
calcium interactions. Although further studies are nee-
ded, the present ﬁndings suggest that phosphorylation
may also inﬂuence amelogenin conformation and sub-
sequent protein–mineral interactions during the early
stages of amelogenesis.
Acknowledgement – This work was supported by grant DE-
016376 (to H.C.M) from the National Institute of Dental and
Craniofacial Research. Use of beamline X9 and the National
Synchrotron Light Source, Brookhaven National Laboratory,
was supported by the US Department of Energy, Oﬃce of
Science, Oﬃce of Basic Energy Sciences, under contract no.
DE-AC02-98CH10886.
Conﬂicts of interest – The authors declare that there are no
conﬂicts of interest with respect to this manuscript.
References
1. Nanci A. Enamel: composition, formation and structure. In:
Nanci, ed. Ten Cates oral histology – development, struc-
ture, and function, 7th edn. St Louis: Mosby Inc., 2008; 141–
190.
2. Aichmayer B,MargolisHC, Sigel R, Yamakoshi Y, Simmer
JP, Fratzl P. The onset of amelogenin nanosphere aggregation
studied by small-angle X-ray scattering and dynamic light
scattering. J Struct Biol 2005; 151: 239–249.
3. Aichmayer B,Wiedemann-Bidlack FB,Gilow C, Simmer JP,
Yamakoshi Y, Emmerling F, Margolis HC, Fratzl P.
Amelogenin nanoparticles in suspension: deviations from
spherical shape and pH-dependent aggregation. Biomacromol-
ecules 2010; 11: 369–376.
4. Fincham AG,Moradian-Oldak J, Diekwisch TGH, Lyaruu
DM, Wright JT, Bringas JRP, Slavkin HC. Evidence for
amelogenin ‘‘nanospheres’’ as functional components of secre-
tory-stage enamel matrix. J Struct Biol 1995; 115: 50–59.
5. Beniash E, Simmer JP, Margolis HC. The effect of
recombinant mouse amelogenins on the formation and orga-
nization of hydroxyapatite crystals in vitro. J Struct Biol 2005;
149: 182–190.
6. Wiedemann-Bidlack FB, Beniash E, Yamakoshi Y, Simmer
JP, Margolis HC. pH triggered self-assembly of native and
recombinant amelogenins under physiological pH and tem-
perature in vitro. J Struct Biol 2007; 160: 57–69.
7. Wiedemann-Bidlack FB, Kwak SY, Beniash E, Yamakoshi
Y, Simmer JP, Margolis HC. Effects of phosphorylation on
the self-assembly of native full-length porcine amelogenin and
its regulation of calcium phosphate formation in vitro. J Struct
Biol 2011; 173: 250–260.
8. Kwak SY, Wiedemann-Bidlack FB, Beniash E, Yamakoshi
Y, Simmer JP, Litman A, Margolis HC. Role of 20-kDa
amelogenin (P148) phosphorylation in calcium phosphate for-
mation in vitro. J Biol Chem 2009; 284: 18972–18979.
Fig. 3. Small angle X-ray scattering (SAXS) analyses of non-phosphorylated leucine-rich amelogenin peptide [LRAP()P)] and
phosphorylated leucine-rich amelogenin peptide [LRAP(+P)]. Kratky plots of LRAP()P) and LRAP(+P) at 2 mg ml)1 (A) and
5 mg ml)1 (B–D) were determined in the absence and in the presence of 2.5 mM CaCl2 (A and B) and from 0 to 2.5 mM CaCl2 (C
and D). The plots of LRAP()P) in the absence and presence of calcium showed a similar bell-shaped curve, indicating globular
structures (A, B and D). However, in the absence of calcium (A and B), LRAP(+P) showed a plateau indicating an unfolded
structure, whereas a prominent peak appeared upon the addition of 2.5 mM calcium (A and B). This latter peak was found to become
increasingly more pronounced as a function of calcium concentration (C), suggesting the formation of a more globular LRAP(+P)
structure in the presence of added calcium. I(s), intensity of s; s, scattering vector.
Eﬀect of phosphorylation on LRAP conformation 101
9. Margolis HC, Beniash E, Fowler CE. Role of macromolec-
ular assembly of enamel matrix proteins in enamel formation.
J Dent Res 2006; 85: 775–793.
10. Moradian-Oldak J, Tan J, Fincham AG. Interaction of
amelogenin with hydroxyapatite crystals: an adherence effect
through amelogenin molecular self-association. Biopolymers
1998; 46: 225–238.
11. Tarasevich BJ, Howard CJ, Larson JL, Snead ML, Simmer
JP, PaineM, ShawWJ. The nucleation and growth of calcium
phosphate by amelogenin. J Cryst Growth 2007; 304: 407–415.
12. Wang L, Guan X, Du C, Moradian-Oldak J, Nancollas
GH. Amelogenin promotes the formation of elongated apatite
microstructures in a controlled crystallization system. J Phys
Chem C nanomater interfaces 2007; 111: 6398–6404.
13. PaineML, SneadML. Protein interactions during assembly of
the enamel organic extracellular matrix. J Bone Miner Res 1997;
12: 221–227.
14. Paine ML, Luo W, Zhu DH, Bringas JRP, Snead ML.
Functional domains for amelogenin revealed by compound
genetic defects. J Bone Miner Res 2003; 18: 466–472.
15. Paine ML, Wang HJ, Snead ML. Amelogenin self-assembly
and the role of the proline located within the carboxyl-teleo-
peptide. Connect Tissue Res 2003; 44 (Suppl 1): 52–57.
16. PugachMK, Li Y, Suggs C,Wright JT, AragonMA, Yuan
ZA, Simmons D, Kulkarni AB, Gibson CW. The amelogenin
C-terminus is required for enamel development. J Dent Res
2010; 89: 165–169.
17. Yamakoshi Y, Tanabe T, Oida S, Hu CC, Simmer JP, Fukae
M. Calcium binding of enamel proteins and their derivatives
with emphasis on the calcium-binding domain of porcine
sheathlin. Arch Oral Biol 2001; 46: 1005–1014.
18. Aoba T, Moreno EC. The enamel fluid in the early secretory
stage of porcine amelogenesis: chemical composition and sat-
uration with respect to enamel mineral. Calcif Tissue Int 1987;
41: 86–94.
19. Le Norcy E, Kwak SY,Wiedemann-Bidlack FB, Beniash E,
Yamakoshi Y, Simmer JP, Margolis HC. Leucine-rich ame-
logenin peptides regulate mineralization in vitro. J Dent Res
2011; 90: 1091–1097.
20. Le Norcy E, Kwak SY,Wiedemann-Bidlack FB, Beniash E,
Yamakoshi Y, Simmer JP,Margolis HC. Potential role of the
amelogenin N-terminus in the regulation of calcium phosphate
formation in vitro. Cells Tissues Organs 2011; 194: 188–193.
21. Habelitz S, Denbesten PK,Marshall SJ,Marshall GW, Li
W. Self-assembly and effect on crystal growth of the leucine-
rich amelogenin peptide. Eur J Oral Sci 2006; 114 (Suppl 1):
315–319.
22. Tarasevich BJ, Lea S, Shaw WJ. The leucine rich amelogenin
protein (LRAP) adsorbs as monomers or dimers onto surfaces.
J Struct Biol 2010; 169: 266–276.
23. Le TQ, Gochin M, Featherstone JD, Li W, Denbesten PK.
Comparative calcium binding of leucine-rich amelogenin pep-
tide and full-length amelogenin. Eur J Oral Sci 2006; 114 (Suppl
1): 320–326.
24. Nagano T, Kakegawa A, Yamakoshi Y, Tsuchiya S, Hu JC,
Gomi K, Arai T, Bartlett JD, Simmer JP. Mmp-20 and Klk4
cleavage site preferences for amelogenin sequences. J Dent Res
2009; 88: 823–828.
25. AllaireM, Yang L. Biomolecular solution X-ray scattering at
the National Synchrotron Light Source. J Synchrotron Radiat
2011; 18: 41–44.
26. Konarev PV, Volkov VV, Sokolova AV, Koch MHJ,
SvergunDI. PRIMUS: a Windows PC-based system for small-
angle scattering data analysis. J Appl Cryst 2003; 36: 1277–
1282.
27. Guinier A, Fournet G. Small-angle scattering of X-rays. New
York: Wiley, 1955.
28. Glatter O, Kratky O, eds. Small-angle X-ray scattering.
London: Academic Press, 1982.
29. Kearney KR, Moore PB. X-ray solution-scattering studies of
active and inactive Escherichia coli ribosomal subunits. J Mol
Biol 1983; 170: 381–402.
30. Semisotnov GV, Kihara H, Kotova NV, Kimura K,
Amemiya Y, Wakabayashi K, Serdyuk IN, Timchenko AA,
Chiba K, Nikaido K, Ikura T, Kuwajima K. Protein globu-
larization during folding. A study by synchrotron small-angle
X-ray scattering. J Mol Biol 1996; 262: 559–574.
31. Doniach S. Changes in biomolecular conformation seen
by small angle X-ray scattering. Chem Rev 2001; 101: 1763–
1778.
32. Putnam CD, Hammel M, Hura GL, Tainer JA. X-ray solu-
tion scattering (SAXS) combined with crystallography and
computation: defining accurate macromolecular structures,
conformations and assemblies in solution. Q Rev Biophys 2007;
40: 191–285.
33. Fincham AG, Moradian-Oldak J, Sarte PE. Mass-
spectrographic analysis of a porcine amelogenin identifies a
single phosphorylated locus. Calcif Tissue Int 1994; 55: 398–
400.
34. Buchko GW, Tarasevich BJ, Bekhazi J, Snead ML, Shaw
WJ. A solution NMR investigation into the early events of
amelogenin nanosphere self-assembly initiated with sodium
chloride or calcium chloride. Biochemistry 2008; 47: 13215–
13222.
35. He X, Wu S, Martinez-Avila O, Cheng Y, Habelitz S. Self-
aligning amelogenin nanoribbons in oil-water system. J Struct
Biol 2011; 174: 203–212.
36. Shaw WJ, Ferris K. Structure, orientation, and dynamics of
the C-terminal hexapeptide of LRAP determined using solid-
state NMR. J Phys Chem B 2008; 112: 16975–16981.
37. Beniash E, Metzler RA, Lam RSK, Gilbert PUPA. Tran-
sient amorphous calcium phosphate in forming enamel. J Struct
Biol 2009; 166: 133–143.
102 Le Norcy et al.
